Sign up today to learn more about Zymergen stock
About Zymergen Stock
Zymergen researches, develops, and manufactures microbes for companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize microbial strains that aims to improve economics of in-market products, existing production strains within existing manufacturing processes, and the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.
Jed Dean, Joshua J. Hoffman, and Zachary Serber founded the company in 2013, with headquarters in Emeryville in California and an additional office in Seattle in Washington.
SoftBank Vision Fund
Chief Executive Officer
Chief Science Officer and Co-Founder
TechCrunch - Sep, 9 2020
finance - Sep, 8 2020
genomeweb - Aug, 20 2020
ElectroPages - Apr, 28 2020
Business News Update - Mar, 21 2020
Robotics & Automation - Feb, 23 2020
Record-Bee - Oct, 26 2019
Business Wire - Apr, 17 2019